These mechanisms of action make semaglutide an effective treatment option for individuals with insulin resistance who are struggling with weight management
Stigma around medications still strong Evers says more education is needed to address misconceptions about obesity and the medications used to treat it
Even intentional weight loss correlates with increased depressive symptomatology among overweight or obese adults in the United States, Journal of Affective Disorders Report (2022) Cross-sectional, case-control and longitudinal associations between exposure to glucagon-like peptide-1 receptor agonists and the dispensing of antidepressants, Diabetes, Obesity, and Metabolism (2024) Diabetes and mental health, CDC (2024) Effect of antidepressants on glucagon-like peptide-1 receptor agonist-related weight loss, Journal of Pharmacy Technology (2022) Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis, Obesity (2024) Increased incident rates of antidepressant use during the COVID-19 pandemic: interrupted time-series analysis of a nationally representative sample, Psychological Medicine (2022) KFF Health Tracking Poll May 2024: The publics use and views of GLP-1 drugs, KFF (2024) Obese patients taking antidepressants lost weight on semaglutide, Cleveland Clinic Journal of Medicine (2023) Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies, JAMA Psychiatry (2010) Ozempic dosing, Ozempic Wegovy dosing schedule, Wegovy Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Link Between Diabetes Treatment and Preterm Birth Risk According to findings published in Human Reproduction Open , a leading journal in reproductive medicine, the increased risk of premature birth appears to be linked to diabetes itself rather than the medications
Disclaimer: Compounded peptide therapies may be prescribed offlabel by licensed healthcare providers when clinically appropriate
Exenatide prolonged gastric emptying half-time from 72 minutes to 120 minutes, a 67% increase [2]
